|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2005-10-6
|
|
pubmed:abstractText |
Polycystic ovary syndrome, the most common cause of anovulatory infertility, is characterized by disordered folliculogenesis, notably increased progression from the primordial to the primary stages. This ovarian phenotype is similar to that observed in mice lacking anti-müllerian hormone (AMH).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0021-972X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
90
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
5536-43
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16030171-Adult,
pubmed-meshheading:16030171-Anovulation,
pubmed-meshheading:16030171-Anti-Mullerian Hormone,
pubmed-meshheading:16030171-Cell Count,
pubmed-meshheading:16030171-Female,
pubmed-meshheading:16030171-Glycoproteins,
pubmed-meshheading:16030171-Granulosa Cells,
pubmed-meshheading:16030171-Humans,
pubmed-meshheading:16030171-Immunohistochemistry,
pubmed-meshheading:16030171-Ovarian Follicle,
pubmed-meshheading:16030171-Ovary,
pubmed-meshheading:16030171-Polycystic Ovary Syndrome,
pubmed-meshheading:16030171-Testicular Hormones
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Anti-müllerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries.
|
|
pubmed:affiliation |
Institute of Reproductive and Developmental Biology, Wolfson and Weston Research Centre for Family Health, Imperial College London, Hammersmith Hospital, London W12 0NN, United Kingdom.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
